Literature DB >> 2424997

Measurement of tumour reactive antibody and antibody conjugate by competition, quantitated by flow cytofluorimetry.

R A Robins, R R Laxton, M Garnett, M R Price, R W Baldwin.   

Abstract

Binding of unlabelled monoclonal antibody preparations has been assessed by competition at saturation with fluorochrome labelled homologous antibody for binding to antigen bearing target cells. The extent of competition was measured by quantitative flow cytofluorimetry, and simple mathematical procedures have been developed to allow the interpretation of competition data in terms of antibody binding activity. In the system studied, non-specific (non-competitive) fluorescence was minimal, but an iterative method to calculate its contribution to the measured signal is given. This approach has the advantage that the antibody preparation to be tested does not need to be labelled or modified; this is particularly important when evaluating the binding activity of therapeutic antibody conjugates. Comparison with a well characterized standard antibody preparation provides a rapid, sensitive and accurate quality control procedure. This test is also simple to perform, requiring only the mixing of labelled and unlabelled antibodies with target cells, a single incubation, followed by analysis without washing of the target cells.

Entities:  

Mesh:

Substances:

Year:  1986        PMID: 2424997     DOI: 10.1016/0022-1759(86)90072-4

Source DB:  PubMed          Journal:  J Immunol Methods        ISSN: 0022-1759            Impact factor:   2.303


  4 in total

1.  Human monoclonal anti-idiotypic antibody to the tumour-associated antibody 791T/36.

Authors:  E B Austin; R A Robins; L G Durrant; M R Price; R W Baldwin
Journal:  Immunology       Date:  1989-08       Impact factor: 7.397

2.  Humoral immune responses to XMMCO-791-RTA immunotoxin in colorectal cancer patients.

Authors:  L G Durrant; V S Byers; P J Scannon; R Rodvien; K Grant; R A Robins; R A Marksman; R W Baldwin
Journal:  Clin Exp Immunol       Date:  1989-02       Impact factor: 4.330

3.  Influence of recombinant tumour necrosis factor alpha on blood flow and antibody localisation in human tumour xenografts in nude mice.

Authors:  M V Pimm; S J Gribben; T M Morris
Journal:  J Cancer Res Clin Oncol       Date:  1991       Impact factor: 4.553

4.  Sensitivity of newly established colorectal cell lines to cytotoxic drugs and monoclonal antibody drug conjugates.

Authors:  L G Durrant; M C Garnett; J Gallego; N C Armitage; K C Ballantyne; R A Marksman; J D Hardcastle; R W Baldwin
Journal:  Br J Cancer       Date:  1987-12       Impact factor: 7.640

  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.